Compounds > 8-chloro-cyclic adenosine monophosphate
Page last updated: 2024-08-26

8-chloro-cyclic adenosine monophosphate and Cancer of Ovary

8-chloro-cyclic adenosine monophosphate has been researched along with Cancer of Ovary in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dodds, M; Howie, AF; Langdon, SP; Leonard, RC; Miller, WR; Muir, M; Ritchie, AA; Stockman, PK1
Johnston, PG; McDaid, HM1
Cho-Chung, YS; Longo, DL; Srivastava, AR; Srivastava, RK1
Cho-Chung, YS; Srivastava, RK; Srivastave, AR1
Colic, M; Jandric, D; Medic-Mijacevic, L; Rakic, L; Vucevic, D1
Ahn, YH; Cho-Chung, YS; Hong, SH; Kim, SG; Kim, SN; Park, SD1

Other Studies

6 other study(ies) available for 8-chloro-cyclic adenosine monophosphate and Cancer of Ovary

ArticleYear
Antitumour activity and schedule dependency of 8-chloroadenosine-3',5'-monophosphate (8-ClcAMP) against human tumour xenografts.
    European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:3

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antineoplastic Agents; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypercalcemia; Infusions, Intravenous; Male; Mice; Neoplasm Transplantation; Ovarian Neoplasms; Prostatic Neoplasms; Transplantation, Heterologous; Weight Loss

1998
Synergistic interaction between paclitaxel and 8-chloro-adenosine 3',5'-monophosphate in human ovarian carcinoma cell lines.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:1

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Antineoplastic Combined Chemotherapy Protocols; Drug Synergism; Female; Humans; Ovarian Neoplasms; Paclitaxel; Tumor Cells, Cultured

1999
Synergistic effects of retinoic acid and 8-Cl-cAMP on apoptosis require caspase-3 activation in human ovarian cancer cells.
    Oncogene, 1999, Mar-04, Volume: 18, Issue:9

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amino Acid Sequence; Apoptosis; Caspase 3; Caspases; Cell Cycle; Cell Survival; Cytochrome c Group; DNA-Activated Protein Kinase; DNA-Binding Proteins; Drug Synergism; Enzyme Activation; Female; Humans; Molecular Sequence Data; Nuclear Proteins; Ovarian Neoplasms; Poly(ADP-ribose) Polymerases; Protein Serine-Threonine Kinases; Receptors, Retinoic Acid; Tretinoin; Tumor Cells, Cultured

1999
Synergistic effects of 8-Cl-cAMP and retinoic acids in the inhibition of growth and induction of apoptosis in ovarian cancer cells: induction of retinoic acid receptor beta.
    Molecular and cellular biochemistry, 2000, Volume: 204, Issue:1-2

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Antineoplastic Agents; Apoptosis; Caspase 3; Caspases; Cell Division; Drug Synergism; Female; Humans; Ovarian Neoplasms; Receptors, Retinoic Acid; Tretinoin; Tumor Cells, Cultured

2000
8-Chloro-cAMP modulates apoptosis of thymocytes and thymocyte hybridoma.
    Transplantation proceedings, 2001, Volume: 33, Issue:3

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antibodies, Monoclonal; Apoptosis; CD4 Antigens; CD8 Antigens; Cell Death; Cell Division; Cysteine Proteinase Inhibitors; Female; Humans; Hybridomas; Immunologic Factors; Ovarian Neoplasms; Rats; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocytes; Thymidine

2001
8-Cl-cAMP induces cell cycle-specific apoptosis in human cancer cells.
    International journal of cancer, 2001, Jul-01, Volume: 93, Issue:1

    Topics: 3T3 Cells; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle; CHO Cells; Cricetinae; Cyclic AMP-Dependent Protein Kinases; Female; G2 Phase; HeLa Cells; HL-60 Cells; Humans; K562 Cells; Mice; Mitosis; Neuroblastoma; Ovarian Neoplasms; Receptors, Cyclic AMP; S Phase; Tumor Cells, Cultured

2001